Appraisals of Bangladeshi Medicinal Plants Used by Folk Medicine Practitioners in the Prevention and Management of Malignant Neoplastic Diseases
Cancer is a group of diseases which is categorized to differentiate into diverse cell types and move around in the body to sites of organogenesis that is key to the process of tumor genesis. All types of cancer fall into the group of malignant neoplastic diseases. In Bangladesh, cancer is now one of the foremost killer diseases and its personal, social, and economic bearing are huge. Plant-derived natural compounds (vincristine, vinblastine, etoposide, paclitaxel, camptothecin, topotecan, and irinotecan) are useful for the treatment of cancer. Since there is no extensive ethnobotanical research study in Bangladesh regarding the traditional uses of medicinal plants against neoplasms, therefore, a randomized ethnopharmacological surveys were carried out in 3 districts of Bangladesh to learn more about the usage of anticancer medicinal plants and their chemical constituents having antineoplastic activity. Comprehensive interviews were conducted to the folk medicine practitioners and medicinal plants as pointed out by them were photographed, collected, deposited, and identified at the Bangladesh National Herbarium. The various plant parts have been used by the healers which included whole plant, leaves, fruits, barks, roots, and seeds. This study evaluated considerable potential for discovery of novel compounds with less side effects in the management and prevention of malignancy in cancer.
Cancer is defined as an abnormal growth of cells caused by multiple changes in gene expression leading to deregulated balance of cell proliferation and cell death. Cancer is those tumors  that have developed the ability to invade the surrounding normal tissues. Cancers are caused by exogenous chemical, physical, or biological carcinogens in humans and the mechanisms of carcinogenesis are often multifactorial and complex. Different factors may act by different mechanisms and at different stages of tumor development . A cancerous cell is traveling throughout the body using the blood or lymph systems, destroying healthy tissue in a process called invasion, and that cell manages to make new blood vessels to feed itself in a process called angiogenesis. Tumors may activate angiogenic inhibitors (angiostatin and endostatin) that can modulate angiogenesis at both the primary site and downstream sites of metastasis [3, 4], when a tumor successfully spreads to other parts of the body using the blood or lymph systems known as metastasis.
Cancer is a leading cause of death in the western world. In the United States and a number of European countries, cancer is the second leading destroyer after cardiovascular diseases . Cancer can occur at any age and the average age at the time of diagnosis for cancer is 67 years, and about 76% of all cancers are diagnosed at the age of 55 or older. Although cancer is relatively rare in children, it is the second leading cause of death in children ages of 1–14. In this age, leukemia is the most common cause of death. The overall death rates due to cancer have almost tripled since 1930 for men and gone up over 50% for women . World Health Organization (WHO) estimates that some 84 million people will die of cancer between 2005 and 2015 around the world. In 2007, there were 7.9 million deaths from cancer, around 13 percent of all deaths.
1.1. Cancer Epidemiology in Bangladesh
The National Institute of Cancer Research and Hospital (NICRH) started a cancer registry in 2005 for the first time in Bangladesh along with the World Health Organization (WHO). This report covers three years from 2005 to 2007. Data were collected from 24,847 cancer patients who appeared in the NICRH for the first time . Among them, 10,847 (57.6%) were males. Lung cancer was the leading cancer (17.3%), followed by cancers of breast (12.3%), lymph nodes and lymphatics (8.4%), and cervix (8.4%) for sexes combined in all ages. In males’ lung (25.5%) and in females breast (25.6%) and cervical (21.5%) cancers were predominant. In children aged 14 years or younger, lymphoma, retinoblastoma, osteosarcoma, leukemia, and kidney cancers were most prevalent. Lung cancer in males and cervical and breast cancer in females constitute 38% of all cancers in Bangladesh . According to the WHO data published in April 2011, oral cancer deaths in Bangladesh reached 11,562 or 1.21% of total deaths. The age adjusted death rate is 12.52 per 100,000 of population ranking Bangladesh 4 in the world. There are more than one million (10 lakh) cancer patients in Bangladesh while approximately 200,000 new patients, mostly women, are added every year creating a social burden on the country [8, 9].
Various plants have been used against cancer and tumor in traditional medicine system of Bangladesh since many years. Traditional medicinal knowledge has been a means towards the discovery of many modern medicines . Traditional medicine is practiced in Bangladesh by folk medicine practitioners, also known as Kabirajes who utilize various formulations of medicinal plants in most of their preparations. We have observed that the Kabirajes of various districts and areas use diverse varieties of plants for the treatment of schizophrenia and psychotic problems , cardiovascular problems , eye infections , snakebite , diabetes , gastrointestinal disorders [16, 17], HIV/AIDS related infections , rheumatoid arthritis , cattle diseases , and so on.
It was objective of the present study to conduct a randomized ethnopharmacological survey to learn more about the medicinal plants used by folk medicine practitioners of Bangladesh for the treatment of cancer and also to do comprehensive study on several published articles attributed to the in vivo or in vitro anticancer properties of these species. The anticipation was that the medicinal plants used by the Kabirajes can prove to be a useful source for further scientific studies leading to discovering more efficacious antineoplastic drugs.
2.1. Geographical Location of the Survey Area
The present randomized surveys were carried out between October 2013 and March 2014, among the Kabirajes of three districts of Bangladesh, namely, Jessore, Khulna, and Narail. Jessore district geographically is in the southwestern region of Bangladesh. It is located at 23°10′0′′ North, 89°13′0′′ East, bordered by Khulna and Satkhira district to the south, India to the west, Magura and Narail district to the east, and Jhenaidah district to the north. Khulna and Narail district geographically coordinate at 22°48′0′′ North, 89°33′0′′ and 23°10′0′′ North, 89°30′0′′ East, respectively. These three districts (Figure 1) are a part of Khulna division.
The surveys were conducted with the help of a semistructured questionnaire and the guided field-walk method [21, 22]. A total of 5 Kabirajes (36–60 years) were interviewed during the surveys. Kabirajes were asked whether they know about cancer and whether they treat the cancer on a regular basis. Kabirajes were selected based on their confirmatory answer to both questions. The Kabirajes mentioned the plants with which they treated cancer and took the interviewers to spots from where they collected the plants. All interviews were conducted in the Bangla language. The plants were shown along with providing of local names and the parts used. Plant specimens were collected and dried in the field and later brought back to Dhaka for complete identification at the Bangladesh National Herbarium. Nomenclature of the identified species was documented from the plant list database [http://www.theplantlist.org/].
A total of 20 plant species were obtained from the Kabirajes of the three districts surveyed. The results are summarized in Table 1. These plant species are wild and belonged to 17 families. The Acanthaceae, Cucurbitaceae, and Fabaceae family contributed two plants each; the rest of the families contributed one plant each. Whole plant as well as plant parts like leaves, barks, roots, fruits, and seeds was used for preparing medicine. Leaves constituted the major plant part used, forming 40.6% of total uses. Roots, fruits, and seeds each constituted accordingly 15.6%, 12.5%, and 9.4% of total uses. The other plant parts (whole plant, stem, bark, flower, and tuber) mentioned constituted, respectively, 9.4 and 3.1% of total uses (Figure 2).
3.1. Types of Cancer
Among developed countries, the incidence and mortality rates for various cancers are almost the same. Lung cancer is the most common cancer among men in both developing and developed countries of the world and breast cancer is the most common cancer in women. Annually, the global death rate for cancer is estimated to be more than 6 million people and over 22 million individuals have been diagnosed with cancer worldwide . Table 2 has listed the types of cancer.
Many developing countries have intensified their efforts in documenting the ethnomedical data and scientific literature on medicinal plants. In 2000, natural product derivatives were involved in 14 of the top 35 drugs based on worldwide sales . Cancer chemoprevention with phytochemical compounds is a developing plot . Medicinal plants have been used for cancer treatment in many countries of the world from a prolonged period of time [26, 27] and the treatment or prevention is attributed to their safety, low cost, and oral bioavailability as well; natural plant derivatives claimed extensive scientific screening and clinical experiments for the development of anticancer drugs . Over 3000 plants species have been reported to have anticancer properties  and about 35000 plant samples from 20 countries have been collected and around 114,000 extracts were screened against tumor systems used as a primary screen . Clinically active antineoplastic agents should be able to prolong the survival and decrease the leukocyte count of blood of tumor-bearing animals . Examples of some well-known plant-derived antineoplastic lead compounds along with their specific mechanism of actions are summarized in Table 3.
4.1. Appraisement of Bangladeshi Medicinal Plants Used by the Folk Medicine Practitioners for Antineoplastic Properties
Secondary metabolites are compounds belonging to varied chemical groups that exert biological activities both on human and animal cells. Products of secondary metabolites are the main phytochemical constituents with various pharmaceutical properties serving either as protective agents against various pathogens or growth regulatory molecules. These physiological functions are the effects on cancer cells or tumor development inhibition. Plant-derived commercial anticancer drugs (vinblastine and vincristine from Catharanthus roseus) are still produced by isolation from growing plants . In Table 4, we have listed some reported plant-derived chemical compounds from the antineoplastic plants used by the Bangladeshi folk health practitioners in the treatment of cancer.
4.2. Abelmoschus moschatus (Musk Mallow)
Hydroalcoholic seed and leaf extracts of Abelmoschus moschatus exhibited antiproliferative activity against colorectal adenocarcinoma and retinoblastoma human cancer cell lines .
4.3. Acanthus ilicifolius (Holly Mangrove)
The ethanol leaves’ extract of the plant was found  to be cytotoxic towards lung fibroblast cells in MTT assay. Another study  reported that the plant extract has been shown to prevent DNA alterations in a transplantable Ehrlich Ascites carcinoma-bearing murine model and in enlargement of the survival of the animals against the proliferation of ascites tumor. Ethyl acetate extract of the whole plant of A. ilicifolius has a potential cytotoxic activity on HeLa cell and KB cell lines by comet assay . Active compounds of A. ilicifolius flower play a role in killing Artemia salina nauplii and can be considered as potential cytotoxic agents as well as future candidate for cancer therapy .
4.4. Aristolochia indica (Indian Birthwort)
The cytotoxicity and antitumor activity of the chloroform extracts of Aristolochia indica were assessed in human breast cancer cell line by MTT assay using taxol as standard and showed pronounced anticancer activity against Ehrlich Ascites Carcinoma cell line [38, 39]. Aristoloside compound was reported to inhibit carcinogenesis . Aristolochic acid was reported to possess various biological activities including antiadenocarcinoma, antineoplastic , and antitumor activities .
4.5. Borassus flabellifer (Asian Palmyra Palm)
Dammarane triterpenoid 1, isolated from Borassus flabellifer seed coat, inhibits tumor necrosis factor-α and showed good antiproliferative activity against pancreatic cancer cell line. Apoptosis inducing activity was confirmed based on increased sub-G0 phase cell population in cell cycle analysis, loss of mitochondrial membrane potential, elevated levels of cytochrome c, nuclear morphological changes, and DNA fragmentation in MIA PaCa-2 pancreatic cancer cells . B. flabellifer seed coat extracts were screened in another study  for their possible anticancer activity on growth of the HeLa cells and these preliminary studies indicated that even the lower concentrations of plant extract showed significant antiproliferative activity.
4.6. Blumea lacera (Blumea)
There is an in vitro study  that showed that Blumea lacera exhibited broad spectrum antileukemic activity against K562, L1210, P3HR1, and U937 leukemia cells. Methanolic extract of B. lacera leaves has also showed cytotoxic activity against human gastric adenocarcinoma cell line, human colorectal adenocarcinoma cell line, and human breast ductal carcinoma cell line .
4.7. Cannabis sativa (Hemp)
The interest in anticarcinogenic properties of cannabinoids was renewed after the discovery of the endocannabinoid system . The administration of Δ9-THC, Δ8-THC, and cannabinol inhibited the growth of Lewis lung adenocarcinoma cells in vitro as well as in vivo after oral administration in mice . Antitumorigenic mechanisms of cannabinoids are showing their ability to interfere with tumor neovascularization, cancer cell migration, adhesion, invasion, and metastasis . The mechanism of cannabinoids’ anticancer action depends on the ability of their agents to stimulate autophagy-mediated apoptotic cancer cell death; thus, cannabinoid action helps in cancer cell death, impairs tumor angiogenesis, and blocks invasion and metastasis  and cannabinoids are currently also being tested as anticancer agents in phase I/II clinical studies .
4.8. Cucurbita maxima (Pumpkin)
Methanol extract of Cucurbita maxima aerial parts has been performed against Ehrlich Ascites Carcinoma model in mice by Saha et al.  for the antitumor activity and the results revealed that C. maxima possesses significant anticancer activity which may be due to its cytotoxicity and antioxidant properties. L-asparaginase is an antineoplastic agent, identified from fruit of C. maxima, used for treatment of a type of cancer that is acute lymphoblastic leukemia and non-Hodgkin’s lymphoma  as well as being experimentally used as an anticancer agent in human patients [54, 55].
4.9. Dillenia indica (Elephant Apple)
Leaf powder of Dillenia indica is given in treatment of breast cancer . The methanolic extract of D. indica has been found to have significant antileukemic activity in human leukemic cell lines U937, HL60, and K562 . Methanolic extracts of betulinic acid were prepared from the D. indica fruits inducing apoptosis in HT-29 cells via mitochondrial dependent pathway and proving to be a potential therapeutic agent for colon cancer .
4.10. Dioscorea bulbifera (Air Potato)
Petroleum ether fraction of the plant showed potential effects against HepA with microstructure abnormality of HepA cells surface . Immune system modulation might be related to antitumor effects of D. bulbifera rhizome, as reported in S180 and H22 tumor cells bearing mice .
4.11. Emilia sonchifolia (Lilac Tasselflower)
The aqueous and methanolic extracts of the leaves of Emilia sonchifolia gradually exhibit antitumor activities . The n-hexane extract of E. sonchifolia has anticancer effect and is rich in terpenoids  and terpenoids were evaluated for their potential antineoplastic activity in various human cancer cell lines such as gastric, pancreatic, and colon carcinomas .
4.12. Erythrina variegata (Tiger’s Claw)
Steroid derived from the stem bark and the leaves of Erythrina variegata showed anticancer activity against in vitro breast cancer cell T47D . Alkaloids (10,11-dioxoerythratidine and crystagallin A) extracted from the leaves and stem bark of E. variegata plant strongly stated in vitro anticancer activity against breast cancer T47D cell lines in vitro using the Sulforhodamine B (SRB) assay .
4.13. Hygrophila auriculata (Marsh Barbel)
The effect of H. auriculata on carbohydrate metabolizing enzymes in N-nitrosodiethylamine induced hepatocellular carcinoma in rats . The aqueous seed extract from H. auriculata displayed selective cancer cell cytotoxicity with an IC50 value of 0.22 mg mL−1 against colon cancer cells . In vitro study of H. auriculata extracts has reported antitumor and NFκB inhibition . Ahmad et al. reported antitumor activity from plant extract against chemically induced hepatocarcinogenesis in Wister rats .
4.14. Moringa oleifera (Drumstick Tree)
A hydroalcoholic extract of Moringa oleifera study revealed possible chemopreventive potential against chemical carcinogenesis . Different leaf extracts of M. oleifera produced significant cytotoxic effects on human multiple myeloma cultured cell lines . A study  showed that leaves extract of M. oleifera can significantly obstruct the growth of cultured human pancreatic carcinoma cells by inhibiting the NF-κB signaling pathway. Most of the anticancer studies of M. oleifera have not focused on the molecular basis of the tumor-suppressive activity but strongly suggested that it could potentially be a supreme anticancer candidate specific to cancer cells [73, 74].
4.15. Nymphaea nouchali (Blue Water Lily)
The methanolic extract of Nymphaea nouchali roots has showed inhibitory activity towards tumor promoter in the Raji cells .
4.16. Persicaria hydropiper (Water Pepper)
In vitro antiproliferative activity of Polygonum hydropiper (synonymy) extracts was evaluated against cervix epithelial adenocarcinoma, skin epidermoid carcinoma, and breast epithelial adenocarcinoma cells and the results confirmed substantial cell growth inhibitory activity against one or more cell lines .
4.17. Trichosanthes kirilowii (Chinese Cucumber)
A triterpenoid compound named cucurbitacin B isolated from Trichosanthes kirilowii showed the potent inhibitory activity against HIF-1 activation induced by hypoxia in various human cancer cell lines. In vivo studies confirmed the inhibitory effect of cucurbitacin B on the expression of HIF-1α proteins, leading to a decrease growth of HeLa cells in a xenograft tumor model . Cucurbitacin D isolated from the plant has also been shown to suppress proliferation of HT-29 human colon cancer cells  and the compound could be potent therapeutic agent for breast cancer by blocking tumor cell proliferation and inducing apoptosis through suppression of STAT3 activity  and it could also induce apoptosis in human hepatocellular carcinoma cells .
Among twenty plant species, four of the species used by folk medicine practitioners have no strong published data regarding anticancer or cytotoxic activities. These 4 species are C. inerme, M. paniculata, S. sesban, and V. officinalis. From just a brief survey of the literature, it appears that the rest of the sixteen plants used by the Kabirajes in three districts of Bangladesh present considerable potential in the treatment of cancer. Further scientific studies need to be conducted on these plants towards discovery of lead compounds, which can lead to formulation of new drugs for the prevention and management of malignant neoplastic diseases with giving less or no side effects.
Conflict of Interests
The authors declare they have no competing interests.
The authors wish to thank all the medicine practitioners for providing useful information regarding cancer treatment.
B. Vogelstein and K. W. Kinzler, The Genetic Basis of Human Cancer, McGraw-Hill, New York, NY, USA, 2nd edition, 2002.
W. Schulz, Molecular Biology of Human Cancers: An Advanced Student’s Textbook, Springer, Dordrecht, The Netherlands, 2007.View at: Publisher Site
J. Folkman, “Role of angiogenesis in tumor growth and metastasis,” Seminars in Oncology, vol. 29, no. 6, supplement 16, pp. 15–18, 2002.View at: Google Scholar
Cancer Registry Report 2005–2007, National Institute of Cancer Research and Hospital, Dhaka, Bangladesh, December 2009.
C. M. Cotton, Ethnobotany: Principle ad Application, John Wiley & Sons, New York, NY, USA, 1996.
M. N. Ahmed and M. N. K. Azam, “Traditional knowledge and formulations of medicinal plants used by the traditional medical practitioners of Bangladesh to treat schizophrenia like psychosis,” Schizophrenia Research and Treatment, vol. 2014, Article ID 679210, 10 pages, 2014.View at: Publisher Site | Google Scholar
M. N. K. Azam, MA. Mannan, and M. N. Ahmed, “Medicinal plants used by the traditional medical practitioners of Barendra and Shamatat. (Rajshahi & Khulna Division) region in Bangladesh for treatment of cardiovascular disorders,” Journal of Medicinal Plants Studies, vol. 2, no. 2, pp. 9–14, 2014.View at: Google Scholar
M. N. K. Azam, S. Biswas, and M. N. Ahmed, “A cross-sectional study of ethnopharmacology in the Noakhali district of Bangladesh and exploring potential ocular immunostimulatory activity of the medicinal plants for the treatment of eye infections,” PharmacologyOnline, vol. 1, no. 1, pp. 77–89, 2015.View at: Google Scholar
M. F. Kadir, M. S. Bin Sayeed, T. Shams, and M. M. K. Mia, “Ethnobotanical survey of medicinal plants used by Bangladeshi traditional health practitioners in the management of diabetes mellitus,” Journal of Ethnopharmacology, vol. 144, no. 3, pp. 605–611, 2012.View at: Publisher Site | Google Scholar
M. A. H. Mollik, M. R. Faruque, K. Akter, M. T. Islam, M. F. Hossain, and D. Sen, “Ethnomedicinal survey of medicinal plants used as remedy for HIV/AIDS related infections by the traditional medicinal practitioners of Bangladesh,” in Proceedings of the 18th International AIDS Conference (AIDS ’10), Abstract no. MOPE0213, Vienna, Austria, July 2010.View at: Google Scholar
M. Rahmatullah, R. Jahan, A. K. Azad et al., “A randomized survey of medicinal plants used by folk medicinal practitioners in six districts of bangladesh to treat rheumatoid arthritis,” Advances in Natural and Applied Sciences, vol. 4, no. 2, pp. 124–127, 2010.View at: Google Scholar
M. H. Rashid, R. Tanzin, K. C. Ghosh, R. Jahan, M. A. Khaun, and M. Rahmatullah, “An ethnoveterinary survey of medicinal plants used to treat cattle diseases in Birishiri area, Netrakona district, Bangladesh,” Advances in Natural and Applied Sciences, vol. 4, no. 1, pp. 10–13, 2010.View at: Google Scholar
P. Maundu, “Methodology for collecting and sharing indigenous knowledge: a case study,” Indigenous Knowledge and Development Monitor, vol. 3, pp. 3–5, 1995.View at: Google Scholar
M. N. Alexiades, “Collecting ethnobotanical data,” in Selecting Guidelines for Ethnobotanical Research, pp. 53–94, The New York Botanical Garden Press, 1996.View at: Google Scholar
D. M. Parkin, F. Bray, J. Ferlay, and P. Pisani, “Global cancer statistics, 2002,” CA: A Cancer Journal for Clinicians, vol. 55, no. 2, pp. 74–108, 2005.View at: Google Scholar
J. L. Hartwell, Plants Used against Cancer. A Survey, Quarterman Publications, Lawrence, Mass, USA, 1982.
E. K. Spiridon and G. B. Maria, Plants That Fight Cancer, CRC Press, 2004.
M. Z. Gul, L. M. Bhakshu, F. Ahmad, A. K. Kondapi, I. A. Qureshi, and I. A. Ghazi, “Evaluation of Abelmoschus moschatus extracts for antioxidant, free radical scavenging, antimicrobial and antiproliferative activities using in vitro assays,” BMC Complementary and Alternative Medicine, vol. 11, article 64, 2011.View at: Publisher Site | Google Scholar
P. V. Khajure and J. L. Rathod, “Potential anticancer activity of Acanthus ilicifolius extracted from the Mangroves Forest of Karwar, West Cost of India,” World Journal of Science and Technology, vol. 1, pp. 1–6, 2011.View at: Google Scholar
V. Subramaniyan, R. Saravanan, D. Baskaran, and S. Ramalalingam, “In vitro free radical scavenging and anticancer potential of Aristolochia indica L. against MCF-7 cell line,” International Journal of Pharmacy and Pharmaceutical Sciences, vol. 7, no. 6, pp. 392–396, 2015.View at: Google Scholar
H. Nagasawa, G. Wu, and H. Inatomi, “Effects of aristoloside, a component of guan-mu-tong (Caulis aristolochiae manshuriensis), on normal and preneoplastic mammary gland growth in mice,” Anticancer Research, vol. 17, no. 1, pp. 237–240, 1997.View at: Google Scholar
P. Garodia, H. Ichikawa, N. Malani, G. Sethi, and B. B. Aggarwal, “From ancient medicine to modern medicine: ayurvedic concepts of health and their role in inflammation and cancer,” Journal of the Society for Integrative Oncology, vol. 5, no. 1, pp. 25–37, 2007.View at: Publisher Site | Google Scholar
N. S. Yarla, R. Azad, M. Basha et al., “5-lipoxygenase and cyclooxygenase inhibitory dammarane triterpenoid 1 from borassus flabellifer seed coat inhibits tumor necrosis factor-α secretion in LPSInduced THP-1 human monocytes and induces apoptosis in MIA PaCa-2 pancreatic cancer cells,” Anti-Cancer Agents in Medicinal Chemistry, vol. 15, no. 8, pp. 1066–1077, 2015.View at: Publisher Site | Google Scholar
G. R. Duddukuri, Y. N. Sastry, D. S. V.G. K. Kaladhar, P. A. Babu, K. K. Rao, and K. K. Chaitanya, “Preliminary studies on in vitro anti-tumor activity of tender seed coat extract of Borassus flabellifer L. on hela cell line,” International Journal of Current Research, vol. 3, no. 7, pp. 75–77, 2011.View at: Google Scholar
P. Tiwari, G. Aluja, A. S. Pandey, and N. Sharma, “Isolation and biological evaluation of some phytoconstituents from Blumea lacera (Burn F.) D.C,” International Journal of Pharmacy & Pharmaceutical Sciences, vol. 4, supplement 4, pp. 148–150, 2012.View at: Google Scholar
A. E. Munson, L. S. Harris, M. A. Friedman, W. L. Dewey, and R. A. Carchman, “Antineoplastic activity of cannabinoids,” Journal of the National Cancer Institute, vol. 55, no. 3, pp. 597–602, 1975.View at: Google Scholar
P. Saha, U. K. Mazumder, P. K. Haldar et al., “Anticancer activity of methanol extract of Cucurbita maxima against Ehrlich as-cites carcinoma,” International Journal of Research in Pharmaceutical Sciences, vol. 2, no. 1, pp. 52–59, 2011.View at: Google Scholar
A. Shrivastava, A. A. Khan, S. K. Jain et al., “Biotechnological advancement in isolation of anti-neoplastic compounds from natural origin: a novel source of L-asparaginase,” Acta Biomedica, vol. 81, no. 2, pp. 104–108, 2010.View at: Google Scholar
M. Anisuzzaman, A. H. M. M. Rahman, M. Harun-Or-Rashid, A. T. M. Naderuzzaman, and A. K. M. R. Islam, “An ethnobotanical study of madhupur, Tangail,” Journal of Applied Polymer Science, vol. 3, no. 7, pp. 519–530, 2007.View at: Google Scholar
D. Dutta, A. Sarkar, B. Chakraborty, C. Chowdhury, and P. Das, “Induction of apoptosis by a potent Betulinic acid derivative in Human colon carcinoma HT-29 cells,” International Journal of Scientific and Research Publications, vol. 5, no. 2, pp. 1–7, 2015.View at: Google Scholar
Z.-L. Yu, X.-R. Liu, M. McCulloch, and J. Gao, “Anticancer effects of various fractions extracted from Dioscorea bulbifera on mice bearing HepA,” Zhongguo Zhong Yao Za Zhi, vol. 29, no. 6, pp. 563–567, 2004.View at: Google Scholar
B. S. Shylesh, S. Ajikumaran Nair, and A. Subramoniam, “Induction of cell-specific apoptosis and protection from Dalton’s lymphoma challenge in mice by an active fraction from Emilia sonchifolia,” Indian Journal of Pharmacology, vol. 37, no. 4, pp. 232–237, 2005.View at: Publisher Site | Google Scholar
T. Herlina, Nasrudin, U. Supratman, A. Subamas, A. Sutardjo, and H. Hayashi, “An isoflavonoid, warangalone from the stem bark of dadap ayam (Erythrina variegata),” Journal of Basic Sciences, vol. 9, no. 1, pp. 45–47, 2008.View at: Google Scholar
M. P. Balasubramaniam and S. Premkumari, “Effects of Hygrophila auriculata on carbohydrate metabolizing enzymes in N-nitrosodiethylamine induced hepatocellular Carcinoma in rats,” Journal of Herbal Medicine, vol. 1, pp. 85–90, 2012.View at: Google Scholar
R. Bharali, J. Tabassum, and M. R. H. Azad, “Chemomodulatory effect of Moringa oleifera, lam, on hepatic carcinogen metabolising enzymes, antioxidant parameters and skin papillomagenesis in mice,” Asian Pacific Journal of Cancer Prevention, vol. 4, no. 2, pp. 131–139, 2003.View at: Google Scholar
L. Berkovich, G. Earon, I. Ron, A. Rimmon, A. Vexler, and S. Lev-Ari, “Moringa Oleifera aqueous leaf extract down-regulates nuclear factor-κB and increases cytotoxic effect of chemotherapy in pancreatic cancer cells,” BMC Complementary and Alternative Medicine, vol. 13, article 212, 2013.View at: Publisher Site | Google Scholar
S. R. Kim, H. S. Seo, H.-S. Choi et al., “Trichosanthes kirilowii ethanol extract and cucurbitacin D inhibit cell growth and induce apoptosis through inhibition of STAT3 activity in breast cancer cells,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 975350, 9 pages, 2013.View at: Publisher Site | Google Scholar
N. Takahashi, Y. Yoshida, T. Sugiura, K. Matsuno, A. Fujino, and U. Yamashita, “Cucurbitacin D isolated from Trichosanthes kirilowii induces apoptosis in human hepatocellular carcinoma cells in vitro,” International Immunopharmacology, vol. 9, no. 4, pp. 508–513, 2009.View at: Publisher Site | Google Scholar
L. Pan, H.-B. Chai, and A. D. Kinghorn, “Discovery of new anticancer agents from higher plants,” Frontiers in Bioscience, vol. 4, no. 1, pp. 142–156, 2012.View at: Google Scholar
Y.-H. Hsiang, M. G. Lihou, and L. F. Liu, “Arrest of replication forks by drug-stabilized topoisomerase I-DNA cleavable complexes as a mechanism of cell killing by camptothecin,” Cancer Research, vol. 49, no. 18, pp. 5077–5082, 1989.View at: Google Scholar
D. C. Zhou, R. Zittoun, and J. P. Marie, “Homoharringtonine: an effective new natural product in cancer chemotherapy,” Bulletin du Cancer, vol. 82, no. 12, pp. 987–995, 1995.View at: Google Scholar
H. Itokawa, X. Wang, and K.-H. Lee, “Homoharringtonine and related compounds,” in Anticancer Agents from Natural Products, M. Cragg Gordon, G. Kingston David, and J. Newman David, Eds., pp. 47–70, CRC/Taylor & Francis, Boca Raton, Fla, USA, 2005.View at: Google Scholar
G. Sa, T. Das, S. Banerjee, and J. Chakraborty, “Curcumin: from exotic spice to modern anticancer drug,” Al Ameen Journal of Medical Sciences, vol. 3, no. 1, pp. 21–37, 2010.View at: Google Scholar
B. B. Aggarwal, A. Bhardwaj, R. S. Aggarwal, N. P. Seeram, S. Shishodia, and Y. Takada, “Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies,” Anticancer Research, vol. 24, no. 5, pp. 2783–2840, 2004.View at: Google Scholar
R. Li, C. Wang, T. Chen, and P. Chen, “Quantitative proteomic analysis of cold-responsive proteins in Abelmoschus moschatus,” Journal of Animal & Plant Sciences, vol. 14, no. 3, pp. 2006–2023, 2012.View at: Google Scholar
M. N. Ahmed, T. Sultana, M. N. K. Azam, and M. Rahmatullah, “A preliminary antihyperglycemic and antinociceptive activity evaluation of a mangrove species Acanthus ilicifolius L. leaves in mice,” Asian Journal of Traditional Medicines, vol. 9, no. 6, pp. 143–149, 2014.View at: Google Scholar
K. P. Tiwara, P. K. Minocha, and M. Masood, “Acanthicifoline—a new alkaloid from Acanthus ilicifolius,” Polish Journal of Chemistry, vol. 54, pp. 857–858, 1980.View at: Google Scholar
S. Subashini, V. Rameshkannan, and P. Mani, “Phytochemical and GC-MS analysis of bioactive compounds from borassus flabellifer linn from root,” European Journal of Molecular Biology and Biochemistry, vol. 2, no. 3, pp. 148–152, 2015.View at: Google Scholar
K. R. Dutta, S. Banerjee, and A. Mitra, “Medicinal plants of West midnapore, India: emphasis on phytochemical containment having role on oral cancer,” International Journal of Phytopharmacology, vol. 3, no. 2, pp. 198–208, 2012.View at: Google Scholar
D. Gandhi and P. Mehta, “Dillenia indica Linn. and Dillenia pentagyna Roxb.: pharmacognostic, phytochemical and therapeutic aspects,” Journal of Applied Pharmaceutical Science, vol. 3, no. 11, pp. 134–142, 2013.View at: Google Scholar
J. J. Gao, D. L. Cheng, and X. P. Liu, “Chemical constituents of Emilia sonchifolia L. DC,” Zhongguo Zhong Yao Za Zhi, vol. 18, no. 2, pp. 102–127, 1993.View at: Google Scholar
A. Ghani, Medicinal Plants of Bangladesh with Chemical Constituents and Uses, Asiatic Society of Bangladesh, Dhaka, Bangladesh, 2003.
P. Bairaj and S. Nagarajan, “Apigenin 7-O-glucuronide from the flowers of Asteracantha longifolia Nees,” Indian Drugs, vol. 19, pp. 150–152, 1982.View at: Google Scholar
V. V. Parashar and H. Singh, “Investigation of Astercantha longifolia Nees,” Indian Journal of Pharmacology, vol. 27, no. 4, pp. 109–113, 1965.View at: Google Scholar
T. R. Govindachari, K. Nagarajan, and B. R. Pai, “Isolation of lupeol from the root of Asteracantha longifolia nees,” Indian Journal of Scientific Research B, vol. 16, article 72, 1957.View at: Google Scholar
C. Quasim and N. L. Dutta, “Reported the prescence of stigmasterol in the root of Asteracantha longifolia Nees,” Journal of Indian Chemical Society, vol. 44, article 82, 1967.View at: Google Scholar
C. K. Bose, “Possible role of Moringa oleifera Lam. root in epithelial ovarian cancer,” Medscape General Medicine, vol. 9, article 26, 2007.View at: Google Scholar
A. K. M. M. Huq, J. A. Jamal, and J. Stanslas, “Ethnobotanical, phytochemical, pharmacological, and toxicological aspects of Persicaria hydropiper (L.) delarbre,” Evidence-Based Complementary and Alternative Medicine, vol. 2014, Article ID 782830, 11 pages, 2014.View at: Publisher Site | Google Scholar
M. Kathiresh, P. D. Suganya, and M. Saravanakumar, “Bioactive compounds in Sesbania sesban flower and its antioxidant and antimicrobial activity,” Journal of Pharmacy Research, vol. 5, no. 1, pp. 293–390, 2012.View at: Google Scholar
M. Valyova, V. Hadjimitova, S. Stoyanov, Y. Ganeva, and I. Trayko Petkov, “Free radical scavenging activity of extracts from Bulgarian Veronica officinalis L. and GC-MS analysis of ethanol extract,” The Internet Journal of Aesthetic and Antiaging Medicine, vol. 2, no. 1, pp. 1–4, 2008.View at: Google Scholar